Literature DB >> 17035436

What is worse for asthma control and quality of life: depressive disorders, anxiety disorders, or both?

Kim L Lavoie1, Simon L Bacon, Silvana Barone, Andre Cartier, Blaine Ditto, Manon Labrecque.   

Abstract

BACKGROUND: The high burden of asthma appears to be related to poor asthma control. Although previous studies have reported associations between depressive disorders (DDs) and anxiety disorders (ADs) and worse asthma control and quality of life, the relative impact of these disorders on asthma control and quality of life has not been explored. This study evaluated the relative impact of having a DD and/or AD on asthma control and quality of life.
METHOD: Five hundred four consecutive adults with confirmed, physician-diagnosed asthma underwent a brief, structured psychiatric interview using the Primary Care Evaluation of Mental Disorders. Asthma control and asthma-related quality of life were assessed using the Asthma Control Questionnaire (ACQ) and the Asthma Quality of Life Questionnaire (AQLQ). All patients underwent standard spirometry.
RESULTS: Thirty-one percent of patients (n = 157) met the diagnostic criteria for one or more psychiatric disorders (8% had DD only, 12% had AD only, and 11% had both). Analyses revealed independent effects for DDs on total ACQ scores (p < 0.01), and for DDs and ADs on total AQLQ scores and all four AQLQ subscales (p < 0.05). There were no interaction effects.
CONCLUSIONS: Results suggest that DDs and ADs are associated with worse asthma-related quality of life, but only DDs are associated with worse asthma control. Interestingly, having both a DD and an AD did not confer additional risk for worse asthma control or quality of life. Physicians may want to consider the differential impact of negative mood states when assessing levels of asthma control and quality of life.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17035436     DOI: 10.1378/chest.130.4.1039

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  52 in total

Review 1.  Metabolic/inflammatory/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target.

Authors:  W Swardfager; M Hennebelle; D Yu; B D Hammock; A J Levitt; K Hashimoto; A Y Taha
Journal:  Neurosci Biobehav Rev       Date:  2018-02-02       Impact factor: 8.989

Review 2.  Treatment of asthma and food allergy with herbal interventions from traditional chinese medicine.

Authors:  Xiu-Min Li
Journal:  Mt Sinai J Med       Date:  2011 Sep-Oct

3.  Long-term predictors of anxiety and depression in adult patients with asthma.

Authors:  Marina Labor; Slavica Labor; Iva Jurić; Vladimir Fijačko; Sanja Popović Grle; Davor Plavec
Journal:  Wien Klin Wochenschr       Date:  2017-04-18       Impact factor: 1.704

4.  Factors associated with depressive symptoms in uncontrolled asthmatics.

Authors:  Rita Mangold; Gary A Salzman; Karen B Williams; Nicola A Hanania
Journal:  J Asthma       Date:  2017-09-07       Impact factor: 2.515

Review 5.  Psychosocial factors and behavioral medicine interventions in asthma.

Authors:  Thomas Ritz; Alicia E Meuret; Ana F Trueba; Anja Fritzsche; Andreas von Leupoldt
Journal:  J Consult Clin Psychol       Date:  2012-10-01

6.  Predictors of perceived asthma control among patients managed in primary care clinics.

Authors:  Owis Eilayyan; Amede Gogovor; Nancy Mayo; Pierre Ernst; Sara Ahmed
Journal:  Qual Life Res       Date:  2014-05-08       Impact factor: 4.147

7.  Associations between distress tolerance and asthma symptoms and quality of life.

Authors:  Talya Alsaid-Habia; Alison C McLeish; Kristen M Kraemer
Journal:  J Asthma       Date:  2018-10-04       Impact factor: 2.515

8.  Asthma and Mood Disorders.

Authors:  Anupama Kewalramani; Mary E Bollinger; Teodor T Postolache
Journal:  Int J Child Health Hum Dev       Date:  2008

9.  Asthma, life events and psychiatric disorders: a population-based study.

Authors:  Yanxia Lu; Liang Feng; Leslie Lim; Tze Pin Ng
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-01-31       Impact factor: 4.328

Review 10.  Potential adverse effects of bronchodilators in the treatment of airways obstruction in older people: recommendations for prescribing.

Authors:  Preeti Gupta; M Sinead O'Mahony
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.